Pneumococcal 24-Valent Conjugate Vaccine(Ruizhou Biotechnology)

24价肺炎球菌多糖结合疫苗（瑞宙生物科技）

Report date: 2026/05/20 20:02:01

Base Information

Drug NamePneumococcal 24-Valent Conjugate Vaccine(Ruizhou Biotechnology)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Conjugated vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccine +[5] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsPneumonia, PneumococcalPneumococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesRui Zhou Biomedical (Zhejiang) Co LtdChangchun Ruizhou Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRui Zhou Biomedical (Zhejiang) Co LtdShanghai Microdow Biotechnology Co LtdChangchun Ruizhou Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPneumonia, PneumococcalPneumococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A